Speakers Aaron Yarlas Director, Clinical Outcome Assessments Ionis Pharmaceuticals Aimee Jackson Chief Scientific Officer Atalanta Therapeutics Anne Valat Principal Scientist Bolden Therapeutics Apoorva Sarode Principal Scientist Genentech Inc Benjamin Bleier Associate Professor Harvard Medical School Dan Elbaum Chief Scientific Officer QurAlis Corp. Eric Green Chief Scientific Officer Maze Therapeutics Graham Dempsey Chief Scientific Officer Q-State Biosciences Helene Tran Oligonucleotide Program Lead Servier Hideaki Tomita Group leader (R&D Biology) Luxna Biotech Jessica Hurt Director, Genomic Targets Biology Biogen Idec John Lewis Chief Executive Officer Entos Pharmaceuticals Julia Alterman Assistant Professor University of Massachusetts Medical School Mansoor Amiji University Distinguished Professor Northwestern University Marjoke Debets Director - Research & Development Eli Lilly & Co. Mark DeAndrade Associate Director, CNS Gene Therapy Korro Bio Meena Meena Senior Vice President Stoke Therapeutics Inc. Michael Breen Assistant Professor Icahn School of Medicine at Mount Sinai Miguel Rodriguez de los Santos Postdoctoral Fellow, Icahn School of Medicine Icahn School of Medicine at Mount Sinai Nicole Datson Chief Development Officer Vico Therapeutics BV Nikolaos Giagtzoglou Associate Director CNS Discovery CAMP4 Therapeutics Paul Peng Director Biogen Steven Petrou Chief Scientific Officer PRAXIS Sudhir Agrawal President ARNAY Sciences Thomas Gaj Assistant Professor University of Illinois Wen-Hsuan Chang Head of Target Validation AcuraStem William Drury Director Chemistry Innovation Deep Genomics Xiaobo Zhong Professor University of Connecticut Zhen LI Chief Executive Officer ADARx Pharmaceuticals Inc. EVENT GUIDE